Zloćudni rak kestenjače (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zloćudni rak kestenjače" in Serbian language version.

refsWebsite

Global rank Serbian rank

22doi.org

2^nd place

4^th place

19nih.gov

4^th place

8^th place

6archive.org

6^th place

5^th place

1cancer.gov

1,684^th place

703^rd place

archive.org

Merrill, R. M.; Stephenson RA. (2000). „Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening”. Journal of Urology. 163 (2): 503—10. PMID 10647666. doi:10.1016/S0022-5347(05)67912-8. .
Whitmore, Willet F. (1984). „Natural history and staging of prostate cancer”. Urol Clin North Am. 11 (2): 205—20. doi:10.1016/S0094-0143(21)00182-8.
Canto, E. I.; Shariat, S. F.; Slawin, K. M. (2003). „Biochemical staging of prostate cancer”. Urol Clin North Am. 30 (2): 263—277. PMID 12735503. doi:10.1016/S0094-0143(02)00183-0.
Djavan, B. B.; Remzi, M. M.; Marberger, M. M. (2003). „When to biopsy and when to stop biopsying”. Urol Clin North Am. 30 (2): 253—62. PMID 12735502. doi:10.1016/S0094-0143(02)00188-X.
Purohit, R. S.; Shinohara, K; Meng, M. V.; Carroll, P. R. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. doi:10.1016/S0094-0143(02)00184-2.
Purohit RS, Shinohara K, Meng MV, Carroll PR. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2.

cancer.gov

seer.cancer.gov

„Cancer Stat Facts: Prostate Cancer”. National Cancer Institute . USA.gov. Приступљено 9. 12. 2017.

doi.org

Center, M. M.; Jemal, A; Lortet-Tieulent J i sur (2012). „International variation in prostate cancer incidence and mortality rates”. Eur Urol. 61 (6): 1079—92. PMID 22424666. doi:10.1016/j.eururo.2012.02.054.
Merrill, R. M.; Stephenson RA. (2000). „Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening”. Journal of Urology. 163 (2): 503—10. PMID 10647666. doi:10.1016/S0022-5347(05)67912-8. .
Carter, B. S.; Bova, G. S.; Bety TH i sur (1993). „Hereditary prostate cancer: epidemiologic and clinical features”. Journal of Urology. 150 (3): 797—802. PMID 8345587. doi:10.1016/S0022-5347(17)35617-3. .
Albano, J. D.; Ward, E; Jemal A i sur (2007). „Cancer mortality in the United States by education level and race”. J Natl Cancer Inst. 99 (18): 1384—94. PMID 17848670. doi:10.1093/jnci/djm127.
Yokoyama M, Seki N, Tamai M, Takeuchi M (1989). „Benign prostatic hyperplasia in patients castrated in his youth”. Journal of Urology. 142 (1): 134—5. PMID 2471841. doi:10.1016/S0022-5347(17)38685-8.
Reynolds, M. A. (2008). „Molecular alterations in prostate cancer”. Cancer Lett. 271: 13—24. PMID 18554779. doi:10.1016/j.canlet.2008.04.047.
Catalona, W. J.; Richie, J. P.; De Kernion JB (1994). „Comparison of prostate specific antigen concentrations versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristics courves”. Journal of Urology. 152 (6 Pt 1): 2031—5. PMID 7525994. doi:10.1016/S0022-5347(17)32299-1.
Ahlering, T. E.; Skarecky, D. W.; McLaren, C. E.; Weinberg, A. C. (2002). „Seminal vesicle involvement in patients with D1 disease predicts early prostate specific antigen recurrence and metastasis after radical prostatectomy and early androgen ablation”. Cancer. 94 (6): 1648—53. PMID 11920524. doi:10.1002/cncr.10378.
Whitmore, Willet F. (1984). „Natural history and staging of prostate cancer”. Urol Clin North Am. 11 (2): 205—20. doi:10.1016/S0094-0143(21)00182-8.
Gnanapragasam, V. J.; Kumar, V; Langton, D.; Pickard, R. S.; Leung, H. Y. (2006). „Outcome of transurethral prostatectomy for the palliative management of lower urinary tract symptoms in men with prostate cancer”. International Journal of Urology. 13 (6): 711—5. PMID 16834648. doi:10.1111/j.1442-2042.2006.01391.x. .
Canto, E. I.; Shariat, S. F.; Slawin, K. M. (2003). „Biochemical staging of prostate cancer”. Urol Clin North Am. 30 (2): 263—277. PMID 12735503. doi:10.1016/S0094-0143(02)00183-0.
Djavan, B. B.; Remzi, M. M.; Marberger, M. M. (2003). „When to biopsy and when to stop biopsying”. Urol Clin North Am. 30 (2): 253—62. PMID 12735502. doi:10.1016/S0094-0143(02)00188-X.
Purohit, R. S.; Shinohara, K; Meng, M. V.; Carroll, P. R. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. doi:10.1016/S0094-0143(02)00184-2.
Purohit RS, Shinohara K, Meng MV, Carroll PR. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2.
Heer, R; Raymond, I; Jackson, MJ; Soomro, NA (септембар 2011). „A critical systematic review of recent clinical trials comparing open retropubic, laparoscopic and robot-assisted laparoscopic radical prostatectomy”. Reviews on Recent Clinical Trials. 6 (3): 241—9. PMID 21682688. doi:10.2174/157488711796575513. .
Huang, X; Wang, L; Zheng, X; Wang, X (март 2017). „Comparison of perioperative, functional, and oncologic outcomes between standard laparoscopic and robotic-assisted radical prostatectomy: a systemic review and meta-analysis”. Surgical Endoscopy. 31 (3): 1045—1060. PMID 27444830. doi:10.1007/s00464-016-5125-1. .
Magheli, Ahmed; Busch, Jonas; Leva, Natalia; Schrader, Mark; Deger, Serdar; Miller, Kurt; Lein, Michael (2014). „Comparison of surgical technique (open vs. laparoscopic) on pathological and long term functional outcomes following radical prostatectomy”. BMC Urol. 14: 18. PMID 24506815. doi:10.1186/1471-2490-14-18 . .
Budäus L, Huland H, Graefen M (2012). „Controversies in the management of localized prostate cancer: Radical prostatectomy still the standard of care”. Crit Rev Oncol Hematol. 84: 24—9. PMID 21612943. doi:10.1016/j.critrevonc.2010.09.004. .
Bossi, Alberto (2008). „Modern External-Beam Radiation Therapy for Prostate Cancer: How and When?”. Eur Urol Suppl. 7: 22—8. doi:10.1016/j.eursup.2007.10.003. .
Morris, D. E.; Emami, B; Manch PM i sur (2005). „Evidence-based review of threedimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative”. Int Radiat Oncol Biol Phys. 62 (1): 3—19. PMID 15850897. doi:10.1016/j.ijrobp.2004.07.666. .
Crook, J. (2011). „The role of brachytherapy in the definitive management of prostate cancer”. Cancer Radioth. 15 (3): 230—7. PMID 21514199. doi:10.1016/j.canrad.2011.01.004. .
Pasquier, D.; Ballereau, C. (2008). „Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review”. Int J Radiat Oncol Biol Phys. 72 (4): 972—9. PMID 18954710. doi:10.1016/j.ijrobp.2008.07.026. .

nih.gov

ncbi.nlm.nih.gov

Center, M. M.; Jemal, A; Lortet-Tieulent J i sur (2012). „International variation in prostate cancer incidence and mortality rates”. Eur Urol. 61 (6): 1079—92. PMID 22424666. doi:10.1016/j.eururo.2012.02.054.
Merrill, R. M.; Stephenson RA. (2000). „Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening”. Journal of Urology. 163 (2): 503—10. PMID 10647666. doi:10.1016/S0022-5347(05)67912-8. .
Carter, B. S.; Bova, G. S.; Bety TH i sur (1993). „Hereditary prostate cancer: epidemiologic and clinical features”. Journal of Urology. 150 (3): 797—802. PMID 8345587. doi:10.1016/S0022-5347(17)35617-3. .
Albano, J. D.; Ward, E; Jemal A i sur (2007). „Cancer mortality in the United States by education level and race”. J Natl Cancer Inst. 99 (18): 1384—94. PMID 17848670. doi:10.1093/jnci/djm127.
Yokoyama M, Seki N, Tamai M, Takeuchi M (1989). „Benign prostatic hyperplasia in patients castrated in his youth”. Journal of Urology. 142 (1): 134—5. PMID 2471841. doi:10.1016/S0022-5347(17)38685-8.
Reynolds, M. A. (2008). „Molecular alterations in prostate cancer”. Cancer Lett. 271: 13—24. PMID 18554779. doi:10.1016/j.canlet.2008.04.047.
Catalona, W. J.; Richie, J. P.; De Kernion JB (1994). „Comparison of prostate specific antigen concentrations versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristics courves”. Journal of Urology. 152 (6 Pt 1): 2031—5. PMID 7525994. doi:10.1016/S0022-5347(17)32299-1.
Ahlering, T. E.; Skarecky, D. W.; McLaren, C. E.; Weinberg, A. C. (2002). „Seminal vesicle involvement in patients with D1 disease predicts early prostate specific antigen recurrence and metastasis after radical prostatectomy and early androgen ablation”. Cancer. 94 (6): 1648—53. PMID 11920524. doi:10.1002/cncr.10378.
Gnanapragasam, V. J.; Kumar, V; Langton, D.; Pickard, R. S.; Leung, H. Y. (2006). „Outcome of transurethral prostatectomy for the palliative management of lower urinary tract symptoms in men with prostate cancer”. International Journal of Urology. 13 (6): 711—5. PMID 16834648. doi:10.1111/j.1442-2042.2006.01391.x. .
Canto, E. I.; Shariat, S. F.; Slawin, K. M. (2003). „Biochemical staging of prostate cancer”. Urol Clin North Am. 30 (2): 263—277. PMID 12735503. doi:10.1016/S0094-0143(02)00183-0.
Djavan, B. B.; Remzi, M. M.; Marberger, M. M. (2003). „When to biopsy and when to stop biopsying”. Urol Clin North Am. 30 (2): 253—62. PMID 12735502. doi:10.1016/S0094-0143(02)00188-X.
Purohit RS, Shinohara K, Meng MV, Carroll PR. (2003). „Imaging clinically localized prostate cancer”. Urol Clin North Am. 30 (2): 279—93. PMID 12735504. doi:10.1016/S0094-0143(02)00184-2.
Heer, R; Raymond, I; Jackson, MJ; Soomro, NA (септембар 2011). „A critical systematic review of recent clinical trials comparing open retropubic, laparoscopic and robot-assisted laparoscopic radical prostatectomy”. Reviews on Recent Clinical Trials. 6 (3): 241—9. PMID 21682688. doi:10.2174/157488711796575513. .
Huang, X; Wang, L; Zheng, X; Wang, X (март 2017). „Comparison of perioperative, functional, and oncologic outcomes between standard laparoscopic and robotic-assisted radical prostatectomy: a systemic review and meta-analysis”. Surgical Endoscopy. 31 (3): 1045—1060. PMID 27444830. doi:10.1007/s00464-016-5125-1. .
Magheli, Ahmed; Busch, Jonas; Leva, Natalia; Schrader, Mark; Deger, Serdar; Miller, Kurt; Lein, Michael (2014). „Comparison of surgical technique (open vs. laparoscopic) on pathological and long term functional outcomes following radical prostatectomy”. BMC Urol. 14: 18. PMID 24506815. doi:10.1186/1471-2490-14-18 . .
Budäus L, Huland H, Graefen M (2012). „Controversies in the management of localized prostate cancer: Radical prostatectomy still the standard of care”. Crit Rev Oncol Hematol. 84: 24—9. PMID 21612943. doi:10.1016/j.critrevonc.2010.09.004. .
Morris, D. E.; Emami, B; Manch PM i sur (2005). „Evidence-based review of threedimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative”. Int Radiat Oncol Biol Phys. 62 (1): 3—19. PMID 15850897. doi:10.1016/j.ijrobp.2004.07.666. .
Crook, J. (2011). „The role of brachytherapy in the definitive management of prostate cancer”. Cancer Radioth. 15 (3): 230—7. PMID 21514199. doi:10.1016/j.canrad.2011.01.004. .
Pasquier, D.; Ballereau, C. (2008). „Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review”. Int J Radiat Oncol Biol Phys. 72 (4): 972—9. PMID 18954710. doi:10.1016/j.ijrobp.2008.07.026. .